NAP 226-90 is a metabolite of rivastigmine that is formed by hydrolysis.1
1.Polinsky, R.J.Clinical pharmacology of rivastigmine: A new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's diseaseClin. Ther.20(4)634-647(1998)
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1 g | ¥601.00 | 现货 | 1 | |
| 5 g | ¥1,509.00 | 现货 | 1 | |
| 10 g | ¥2,710.00 | 现货 | 1 | |
| 25 g | ¥6,006.00 | 现货 | 1 |
















NAP 226-90 is a metabolite of rivastigmine that is formed by hydrolysis.1
1.Polinsky, R.J.Clinical pharmacology of rivastigmine: A new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's diseaseClin. Ther.20(4)634-647(1998)